# Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass

> **NCT00587444** · PHASE3 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 270 (actual)

## Conditions studied

- Postoperative Hemorrhage

## Interventions

- **DRUG:** Heparin
- **DRUG:** HH or high heparin
- **DRUG:** heparin concentration HC

## Key facts

- **NCT ID:** NCT00587444
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2009-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00587444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00587444, "Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00587444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*